Page 47 - JCTR-9-4
P. 47

Ali et al. | Journal of Clinical and Translational Research 2023; 9(4): 261-264   263
                                                                disease status and are measured at an interval of 3 months for
                                                                the first 6 months after initial treatment, and then after 6 months
                                                                subsequently [11].
                                                                4. Conclusion
                                                                   In conclusion, isolated raised serum alkaline phosphatase levels
                                                                should always be further investigated to rule out asymptomatic
                                                                patients. Management  includes treatment  with third-generation
                                                                bisphosphonates and pain control. Effective  and time-sensitive
                                                                management  can impart a huge difference in the outcome of
                                                                Paget’s disease.
                                                                Acknowledgments

                                                                   None.
                                                                Funding

                                                                   The  authors  received  no  financial  support  for  the  research,
                                                                authorship, and/or publication of this article.

                                                                Conflicts of Interest
                                                                   The authors have no conflicts of interest associated with the
                                                                material presented in this paper.

        Figure 3. Anterior view of the bone scan showing diffuse uptake of the   Ethics Approval and Consent to Participate
        technetium-99 m in the skull bones.
                                                                   Informed consent was obtained from the patient by the authors.
        confirmation of diagnosis through plain X-ray. Biochemical test   Consent to Participation
        such as an elevated serum ALP levels aid in evaluating the activity
        and progression of PDB and indicate the response to treatment.   Consent was given by the patient to publish her data and images
        Furthermore, recent studies have estimated a significant rise in   in this paper.
        serum osteopontin levels as a marker for active PDB [8]. X-ray   References
        of the skull may manifest  radiolucent  areas around the suture
        lines  typically  in the  occipital  and frontal  bones, an enlarged   [1]   Corral-Gudino L, Tan AJ, Del Pino-Montes J, Ralston SH.
        diploic  space, and focal  osteosclerosis giving cotton  wool   Bisphosphonates  for Paget’s Disease  of Bone  in Adults.
        appearance [3,8,9]. Nonetheless, the putative imaging modality   Cochrane Database Syst Rev 2017;12:CD004956.
        is radionuclide bone scintigraphy (MDP), exhibiting substantially   [2]   Rianon NJ, Des Bordes JK. Paget Disease of Bone for
        increased uptake in the affected bone. Cranial CT scans generally   Primary Care. Am Fam Physician 2020;102:224-8.
        show evidence  of cranial  vault  thickening  [10]. Isolated  skull   [3]   Theodorou  DJ,  Theodorou  SJ, Kakitsubata  Y.  Imaging
        involvement  may include  neurological  complications  such as   of Paget Disease of Bone and Its Musculoskeletal
        hearing loss, headache, bone pains, tinnitus, basilar impression,   Complications:  Review.  AJR  Am J  Roentgenol
        and rarely cranial nerve deficits [9].                        2011;196:S64-75.
          Pagetic  bone pains  are  generally  the  key  indicator  for   [4]   Caicedo  AI, Escobar  VE, Coy Urrea  VA, Charry JS,
        treatment and may recede or disappear with medical therapy. The   Loaiza  JH. Sporadic  Paget’s Disease of the  Bone. Case
        mainstay of treatment is the use of intravenous third-generation   Series  and  Literature  Review.  Rev  Colomb  Reumatol
        bisphosphonates such as zoledronic acid for active PDB which   (English Ed) 2020;27:103-11.
        works by impeding bone resorption through osteoclastic activity
        inhibition, expending an anti-cancerous effect by enhancing the   [5]   Karunakaran  K, Murugesan P, Rajeshwar  G, Babu S.
        proliferation  of gamma  delta  T cells [11], and alleviates  bone   Paget’s Disease of the Mandible. J Oral Maxillofac Pathol
        pains that are believed to be caused by excessive metabolic   2012;16:107-9.
        activity. Zoledronate (zoledronic acid) is administered as 5 mg   [6]   Bone HG. Nonmalignant  Complications  of Paget’s
        given as a single infusion over 15 min. Retreatment is mostly not   Disease. J Bone Miner Res 2006;21:P64-8.
        required as a single infusion balances the bone turnover for about   [7]   Shankar  YU, Misra  SR,  Vineet  DA, Baskaran  P.  Paget
        5 years [8,9,12]. Serum ALP levels are monitored to assess the   Disease of Bone: A  Classic Case Report. Contemp  Clin


                                          DOI: http://dx.doi.org/10.18053/jctres.09.202304.22-00186
   42   43   44   45   46   47   48   49   50   51   52